XR Invest
- Company typePrivate
- Founded2016
- HeadquartersZug, Switzerland
- Headcount1–10
- GTM typeB2B
- OfferingServices
XR Invest firmographics
Firmographics- Name
- XR Invest
- Legal name
- XR Invest
- Website
- https://xr-invest.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
XR Invest industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
- akta.pro secondary industry
- Technology & Software Growth Equity (FSANACAA)
Keywords
Where XR Invest is headquartered
LocationHeadquarters
- HQ city
- Zug
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
XR Invest business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Investment Returns / Capital Gains: As an investment group, XR Invest generates returns through equity investments in medtech and digital health companies. The firm invests in early-to-mid stage companies and realizes returns through acquisitions and exits. Notable exits include Digital Surgery (acquired by Medtronic), Synoste (acquired by Globus Medical), and Precision OS (acquisition/management buy-out).
Marketing channels1 record
XR Invest product offering
Product offeringCore offering
XR Invest is an investment group that makes equity investments in early-to-mid stage companies operating at the intersection of medical technology and digital health. The firm provides growth capital alongside strategic guidance drawing on entrepreneurial, industrial, and clinical expertise, and supports portfolio companies through to exits and acquisitions. Notable exits include Digital Surgery (acquired by Medtronic), Synoste (acquired by Globus Medical), and Precision OS (management buy-out).
Product overview
XR Invest is an investment group, not a product or service company. The firm focuses on investing in companies operating at the nexus of medtech and digital health. Their portfolio represents companies they have backed or acquired, not products or services they offer directly. As an investment vehicle, XR Invest does not provide a unified product platform or SaaS offering.
Differentiator
Problem solved
Functional benefit
Products and services
- XR Invest Portfolio Companies XR Invest's portfolio of equity investments in early-to-mid stage medtech and digital health companies, providing growth capital and strategic guidance to portfolio companies and generating returns through acquisitions and management exits (e.g., Digital Surgery acquired by Medtronic NYSE:MDT, Synoste acquired by Globus Medical NYSE:GMED, Precision OS via management buy-out).
Quantifiable outcome
- Multiple successful exits including acquisitions by Medtronic (NYSE:MDT) and Globus Medical (NYSE:GMED)
- +1 more outcomes
Companies that use XR Invest
Customer profileSegments1 record
Ideal customer profiles1 record
XR Invest technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
XR Invest partnerships and signals
Strategic signalScale indicators3 records
Recent moves6 records
Expansion highlights4 records
XR Invest competitors and assessment
Company assessmentDirect peers
- New Harbor Venture Partners: Swiss-based early-to-growth medtech and digital health venture firm where XR Invest's Beat Merz is also Managing Director. Mirrors XR Invest's sector focus, stage, and geographic footprint (US/Europe/Israel), making it the most directly comparable peer.
- HBM Healthcare Investments: Listed Swiss healthcare investment firm that invests globally in private and public healthcare companies. Beat Merz previously worked at HBM, and it represents a comparable healthcare-focused investment vehicle with similar global mandate.
- Ares Lifesciences: Venture firm focused on life sciences and medical technologies, where Beat Merz previously invested. Directly comparable investment stage, sector focus, and geographic orientation to XR Invest.
- Sofinnova Partners: European venture firm with a dedicated medtech and digital health practice investing in early-to-mid stage companies. Comparable by sector (medtech/digital health), stage, and exit-oriented approach (trade sales to strategics).
- HealthTech Capital: European investor syndicate focused on early-stage healthtech and digital health startups. Comparable in sector focus (digital health) and stage (early-to-mid), with European geographic orientation.
Broad incumbents
- Wellington Partners: European growth investor with a Life Sciences practice alongside technology investments. Comparable in stage (early-to-growth) and sector overlap (medtech/digital health), though broader portfolio than XR Invest's medtech-only focus.
- Andera Partners: European private equity firm (formerly Edmond de Rothschild Capital Partners) with a Life Sciences practice investing in healthcare and medtech. Comparable by sector focus and growth-stage positioning, though broader multi-sector mandate.
- Earlybird Venture Capital: Pan-European early-stage VC with a Health & Tech practice. Comparable in stage and European geography with healthcare vertical overlap, but with significantly broader sector coverage than XR Invest.
- Forbion: European life sciences venture capital firm investing in medical technology, biopharma, and digital health. Comparable by medtech/healthcare focus and growth-stage positioning; significantly larger and broader in mandate.
Emerging players
- XL Health: Berlin-based digital health venture firm where XR Invest's Dominik Mayer previously worked. Directly comparable by digital health focus and early-stage orientation.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
XR Invest social profiles
Digital presenceXR Invest financial estimates
Financial estimateRevenue estimate
Valuation estimate
XR Invest leadership team
Management profileNumber of profiles
Profiles5 records
XR Invest funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
XR Invest M&A and investment
M&A and investmentM&A
Investments4 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about XR Invest
What does XR Invest do?
XR Invest is an investment group that makes equity investments in early-to-mid stage companies operating at the intersection of medical technology and digital health. The firm provides growth capital alongside strategic guidance drawing on entrepreneurial, industrial, and clinical expertise, and supports portfolio companies through to exits and acquisitions. Notable exits include Digital Surgery (acquired by Medtronic), Synoste (acquired by Globus Medical), and Precision OS (management buy-out).
Is XR Invest a public or private company?
XR Invest is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was XR Invest founded?
XR Invest was founded in 2016. It employs 1 to 10 people.
Where is XR Invest based?
XR Invest is headquartered in Zug, Switzerland, in the Europe region.
How does XR Invest make money?
One revenue line is on record: investment Returns / Capital Gains.
Who are XR Invest's main competitors?
Direct peers on record are New Harbor Venture Partners, HBM Healthcare Investments, Ares Lifesciences, Sofinnova Partners and HealthTech Capital. Broad incumbents are Wellington Partners, Andera Partners, Earlybird Venture Capital and Forbion. XL Health is listed as an emerging player.
Does XR Invest have an API?
No public API is recorded for XR Invest.
What industry is XR Invest in?
XR Invest's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity, with a secondary code of FSANACAA, Technology & Software Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.